about
Human cytomegalovirus and transplantation: drug development and regulatory issuesIntrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escapeBioactive Molecules Released From Cells Infected with the Human CytomegalovirusModeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived SystemsPhosphorylation of Golgi Peripheral Membrane Protein Grasp65 Is an Integral Step in the Formation of the Human Cytomegalovirus Cytoplasmic Assembly CompartmentElectrochemical detection of a single cytomegalovirus at an ultramicroelectrode and its antibody anchoring.Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT MiceCytomegalovirus latency and reactivation: recent insights into an age old problem.Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral AntigensThe importance of pathogen load.Crystal Structure of the Human Cytomegalovirus Glycoprotein B.cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells.Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like ResponseVaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.Humanized mouse models of human cytomegalovirus infection.Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens.On the relative roles of background selection and genetic hitchhiking in shaping human cytomegalovirus genetic diversity.Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection agaDistribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseAdditive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.The human cytomegalovirus nuclear egress complex unites multiple functions: Recruitment of effectors, nuclear envelope rearrangement, and docking to nuclear capsids.Human Cytomegalovirus IE2 Protein Disturbs Brain Development by the Dysregulation of Neural Stem Cell Maintenance and the Polarization of Migrating Neurons.Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells.Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability.Role of codon usage and tRNA changes in rat cytomegalovirus latency and (re)activation.Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study.Deep Lessons From the Uncultured.Investigation on the association between thyroid tumorigeneses and herpesviruses.Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population.Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.Crystal Structure of the Human Cytomegalovirus pUL50-pUL53 Core Nuclear Egress Complex Provides Insight into a Unique Assembly Scaffold for Virus-Host Protein Interactions.
P2860
Q26700020-4A218B11-1D46-43AE-B651-663D636B7B57Q26738747-D5D4E9EE-7B6A-4CD8-81BB-1B7E92464705Q26744665-72E17D92-54AA-4F5B-BD24-78E2E4B663EEQ26799933-CB06C71D-8ED9-4B09-9036-24AFBFD8935DQ27343029-3E214C02-2021-4436-8DEA-21EE380A3F5EQ30647288-17EE552E-2445-448A-AA39-A97F57280CF7Q33681388-FDD481B4-5B40-4ABE-975D-39D95076BA2DQ33761454-CA305191-56B8-41CA-B820-CD341E7EF20BQ33802568-48BB56A7-74D9-4AD0-AABC-C6C8FBBE40B3Q34874961-0A90AD79-7FD4-48C0-800F-0ECB538B18D7Q35814428-74E78DBF-40E1-47DE-93F6-6448D139FA33Q35983493-F0F53D79-C272-427A-AA58-663EE7CFC007Q36069672-55BFBC1D-590F-4E7C-997A-EF5D955B938EQ36080805-93B4BDBC-A154-454B-83DD-C913D341758BQ36142747-EF4D3DD3-2B9D-4A85-9630-8C5A0CEA27EBQ36238253-867B87EB-022D-4959-9632-903D360FD6E2Q36331587-64D54A97-DC67-424A-980D-08BE18A211FAQ36446794-C1B16F45-E75C-41F9-9638-A8A781DE3FB6Q36633558-1EA5F00E-3820-4D82-A7E5-1CF6616FAAA2Q37523020-D52E195B-FE21-41E1-A054-FE181E6D5AE8Q37563632-FBAE4F70-387C-4A7C-B176-467D56C8F262Q37747044-6269692B-7AE4-4E4E-BCB8-48F9CBAE5C8AQ38371830-3E576A51-2D99-4A4D-9EBB-11F4DB1E3C04Q38700888-E80033DB-23CC-4592-A636-77260AC33FDBQ38725482-745B0F41-A0C3-4FBB-BF7F-9E8C2936D37AQ38941812-68F061AF-4585-4C2A-8CF3-5C191AB8134AQ38974815-BF5F0E24-E815-48DD-A8BB-097495B8067EQ39035259-E4371C45-BD0A-4736-821C-F8C5A8BF8CC4Q39467030-3E8C5EB4-A904-48E7-8071-9C89E5D1F497Q39545359-0FDC3482-5553-47E5-B239-2D1CAB7D13F2Q39626632-66649FE2-C2D5-4440-BE86-B8EF3ACA26A0Q39997880-F4C21F99-9139-4CC2-8877-22CCCC060659Q40108643-594DC00D-9A1C-4A8F-BED6-29977795E1D3Q40222965-98883EE0-CF0A-4AB0-AD23-FBD0F47292DBQ40262432-EAD59EB6-FFDC-488C-A7F1-9815FBA9F890Q40300872-D63414AC-285C-4399-80B9-C863C9D7C1FBQ40337545-CF8ABB22-83A8-4E18-AE7B-A9891FFFE44EQ40391912-57BA8E86-E2DB-47A4-BC4E-BA7AB40AEDADQ40670318-0E2C5492-DC34-486E-AD0E-72F99C978FACQ41268588-98CC9D7A-A1B3-4776-8053-6AE2970D3A89
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The pathogenesis of human cytomegalovirus.
@en
type
label
The pathogenesis of human cytomegalovirus.
@en
prefLabel
The pathogenesis of human cytomegalovirus.
@en
P2860
P356
P1476
The pathogenesis of human cytomegalovirus
@en
P2093
Ilona Baraniak
Paul Griffiths
P2860
P304
P356
10.1002/PATH.4437
P577
2015-01-01T00:00:00Z